Is the real you trapped behind your eczema or plaque psoriasis?
If you struggle with eczema or plaque psoriasis, consider participating in a clinical trial evaluating a targeted, steroid-free study ointment being developed by Pfizer.
About the Study
The EMPORIA 2 Study is evaluating a steroid-free study ointment being developed by Pfizer to see if it may safely and effectively reduce symptoms of eczema (atopic dermatitis) and plaque psoriasis.
How Do I Qualify for the Study?
You may be able to participate in the study if you:
- Are age 12 or older*
- Have been diagnosed with eczema or plaque psoriasis
There are additional requirements to participate. The clinical research team will discuss those requirements with you to help determine if you are eligible to participate.
*Only people ages 18 or older can take the online prescreener. For those between ages 12 and 17, have a parent or guardian contact your doctor.
Why Should I Take Part in the Study?
If you qualify and decide to participate you will:
- Receive the steroid-free study ointment or a placebo and all study-related medical tests at no charge
- Be monitored by a study physician throughout your participation
- Help advance scientific knowledge and potentially improve the care of people with eczema or plaque psoriasis
- Be reimbursed for any reasonable expenses that you may have as a result of taking part in this clinical research study. These may include parking, meals, or other travel-related expenses. You do not need health insurance to take part.
Your safety while participating is our highest priority. If you have questions or concerns at any point throughout the study, a clinical research team member is available. Your participation is voluntary, and you are free to withdraw at any time. Your privacy will be maintained throughout the study.
Frequently Asked Questions
This section will help answer some important questions you may have.
About the EMPORIA 2 Study
The EMPORIA 2 Study is evaluating a steroid-free study ointment to see if it may safely and effectively reduce symptoms of eczema and plaque psoriasis.
If you qualify and decide to participate, you will be in the clinical research study for up to 21 weeks (just over 5 months). There will be up to 10 visits to the clinical research site.
There are 3 phases to this clinical research study. Screening lasts up to 4 weeks and involves medical tests to see if you qualify for the study. The Treatment period lasts up to 12 weeks and is when you apply the steroid-free study ointment or a placebo daily, along with visiting the clinic (8 times in 12 weeks) for health assessments. About 4 or 5 weeks after you receive the last dose of the study ointment is a Follow-up Visit, during which your overall health and eczema or plaque psoriasis symptoms will be evaluated.
Before you agree to participate, the clinical research team will go over all aspects of the study with you. If you decide to participate, you will be given a document called an Informed Consent Form that provides, in writing, the study’s purpose, assessments, procedures, potential benefits and risks, and precautions. You will have the opportunity to ask any questions you have, then you can decide if participating is right for you.
If you are eligible to participate, the clinical research team can answer all of your questions.
A placebo looks like the study ointment but does not contain any active medicine. Yes, there is a chance that you will receive a placebo. You will be randomly assigned (by chance) to receive the steroid-free study ointment or the placebo. The clinical research team can give you more information about your chances of receiving a placebo.
The clinical research team will respect and protect your privacy and will not share your information except as required by law. Your personal information will be stored with codes that do not identify you. The Informed Consent Form will provide more information about how your privacy will be protected.
Yes, your participation is completely voluntary, so you may withdraw from the study, for any reason, and at any time. If you do decide to leave early, you will be asked to notify the clinical research team before doing so. You will also be asked to return to the clinical research site at least once to complete a final visit and return any unused study ointment.
No. You will get the study treatment or a placebo and all study-related medical tests at no charge. You will be reimbursed for any reasonable expenses that you may have as a result of taking part in this clinical research study. These may include parking, meals, or other travel-related expenses. You do not need health insurance to take part.
No, you do not need your doctor’s permission to participate. However, either you or the study doctor, with your permission, may contact your personal physician to discuss your participation in the clinical research study before you begin and keep your physician up to date about your progress during the study.
About clinical research studies
A clinical research study (also called a clinical trial) tries to answer questions about how medicines work in the people who take them. Researchers run studies to test whether a study medicine is safe and effective. These studies may help doctors find new ways to help prevent, detect, or treat health issues.
Participant safety is the priority in a clinical research study. There are rules in place to help protect the rights, safety, and well-being of people who volunteer for studies. These rules help ensure that research studies follow strict scientific and ethical guidelines.
Before a study can begin, a review board or ethics committee must review and approve the study.
Only patients who meet all eligibility criteria for a clinical research study may take part. The clinical research team will review your medical history and current medical status against the eligibility criteria. You may also be asked to provide information from your medical records to help the clinical research team determine whether or not you may be eligible to participate.
A study medicine is a drug that hasn’t yet been approved for use in the general public. In order to be approved, the study medicine must be tested in research studies to see if it is safe and effective for treating the target disease in certain groups of people.